echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nat Commun: The VEGF-like vaccine showed initial efficacy in neurofibromatosis type 2.

    Nat Commun: The VEGF-like vaccine showed initial efficacy in neurofibromatosis type 2.

    • Last Update: 2020-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Anti-VEGF antibody beva bead monoantigen is effective in the treatment of neurofibromatosis type 2 (NF2).
    theory, vascular endotrative growth factor subjectors (VEGFRs) specific cytotoxic T lymphocytes (CTLs) can kill tumor vascular cells and tumor cells that express VEGFRs.
    , we presented exploratory clinical studies of the VEGFRs peptide vaccine in 7 patients with progressive NF2-based schizophrenic tumors, the results of which were published online in Nat Commun.
    2/5 of patients (40%) who were assessed according to international guidelines had improved hearing, while word recognition scores had increased.
    20 percent reduction in tumor volume was observed in≥ 2 patients, including 1 patient with beval monoantin.
    no serious adverse events associated with vaccines have occurred.
    VEGFR1 specificity and VEGFR2 specific CTL were induced in 6 patients.
    after two patients were vaccinated, VEGFRs were observed to show a significant decrease in expression in the split tumor.
    , the clinical immunotherapy study demonstrated the safety and initial efficacy of VEGFRs peptide vaccination in NF2 patients.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.